A SECRET WEAPON FOR SITUS MBO128

Emily Bodnar’s rating is predicated within the anticipation of sizeable milestones for Agenus in the coming 12 months, especially the prospective submitting of the Biologics License Application (BLA) for his or her lead drug candidate, botensilimab (bot). Agenus has dosed about 900 people with bot throughout several stable tumors, exhibiting a de